The relationship between the daily dose, the plasma concentration of AD-5423 (blonanserin), and its plasma anti-dopamine (D2) and anti-serotonin (5-HT2A) activity, and the plasma serotonin/dopamine (S/D) ratio

Hidenobu Suzuki(Maebashi Red Cross Hospital), A. Aoba(St. Marianna University School of Medicine), Chie Tanaka(St. Marianna University School of Medicine), Y. Morokawa(St. Marianna University School of Medicine), Hitoshi Takagi(Brigham and Women's Hospital), Noboru Yamaguchi(St. Marianna University School of Medicine), Keishi Gen(St. Marianna University School of Medicine)
International Clinical Psychopharmacology
May 1, 2003
Cited by 1


Related Papers